Literature DB >> 22776010

Testosterone replacement therapy improves erythrocyte membrane lipid composition in hypogonadal men.

Petya Angelova1, Albena Momchilova, Diana Petkova, Galya Staneva, Roumen Pankov, Zdravko Kamenov.   

Abstract

AIM: The aim of this study was to investigate the effects of testosterone replacement therapy (TRT) on erythrocyte membrane (EM) lipid composition and physico-chemical properties in hypogonadal men.
METHODS: EM isolated from three patients before and after TRT with injectable testosterone undecanoate or testosterone gel were used for analysis of the phospholipid and fatty acid composition, cholesterol/phospholipid ratio, membrane fluidity, ceramide level and enzyme activities responsible for sphingomyelin metabolism.
RESULTS: TRT induced increase of phosphatidylethanolamine (PE) in the EMs and sphingomyelin. Reduction of the relative content of the saturated palmitic and stearic fatty acids and a slight increase of different unsaturated fatty acids was observed in phosphatidylcholine (PC). TRT also induced decrease of the cholesterol/total phospholipids ratio and fluidization of the EM. DISCUSSION: The TRT induced increase of PE content and the reduction of saturation in the PC acyl chains induced alterations in the structure of EM could result in higher flexibility of the erythrocytes. The increase of the SM-metabolizing enzyme neutral sphingomyelinase, which regulates the content of ceramide in membranes has a possible impact on the SM signaling pathway.
CONCLUSION: We presume that the observed effect of TRT on the composition and fluidity of the EM contributes for improvement of blood rheology and may diminish the thrombosis risk. Larger studies are needed to confirm the findings of this pilot study.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22776010     DOI: 10.3109/13685538.2012.693550

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  6 in total

1.  Kallmann syndrome patient with gender dysphoria, multiple sclerosis, and thrombophilia.

Authors:  Aniruthan Renukanthan; Richard Quinton; Benjamin Turner; Peter MacCallum; Leighton Seal; Andrew Davies; Richard Green; Jane Evanson; Márta Korbonits
Journal:  Endocrine       Date:  2015-03-05       Impact factor: 3.633

2.  The effects of short-term and long-term testosterone supplementation on blood viscosity and erythrocyte deformability in healthy adult mice.

Authors:  Wen Guo; Eric Bachman; Johannes Vogel; Michelle Li; Liming Peng; Karol Pencina; Carlo Serra; Nicolae L Sandor; Ravi Jasuja; Monty Montano; Shehzad Basaria; Max Gassmann; Shalender Bhasin
Journal:  Endocrinology       Date:  2015-03-16       Impact factor: 4.736

Review 3.  Testosterone replacement therapy and cardiovascular disease.

Authors:  Jeremy M Auerbach; Mohit Khera
Journal:  Int J Impot Res       Date:  2022-01-09       Impact factor: 2.408

4.  Developmental Sex Differences in the Metabolism of Cardiolipin in Mouse Cerebral Cortex Mitochondria.

Authors:  Estefanía Acaz-Fonseca; Ana Ortiz-Rodriguez; Ana B Lopez-Rodriguez; Luis M Garcia-Segura; Mariana Astiz
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

5.  Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments.

Authors:  C M Schooling; J V Huang; J V Zhao; M K Kwok; S L Au Yeung; S L Lin
Journal:  EBioMedicine       Date:  2018-01-31       Impact factor: 8.143

6.  Clinical Significance of Low Blood Testosterone Concentration in Men as a Cardiovascular Risk Factor From the Perspective of Blood Rheology.

Authors:  Takashi Hitsumoto
Journal:  Cardiol Res       Date:  2019-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.